Canaccord Genuity Boosts Kinaxis (TSE:KXS) Price Target to C$92.00

Share on StockTwits

Kinaxis (TSE:KXS) had its target price increased by Canaccord Genuity from C$90.00 to C$92.00 in a research note issued to investors on Friday morning, BayStreet.CA reports.

Separately, Royal Bank of Canada boosted their target price on Kinaxis from C$90.00 to C$95.00 and gave the stock an outperform rating in a research note on Monday, May 13th.

Shares of TSE KXS opened at C$82.36 on Friday. The company has a debt-to-equity ratio of 5.99, a quick ratio of 2.65 and a current ratio of 2.73. The firm has a market capitalization of $2.15 billion and a P/E ratio of 130.73. Kinaxis has a 12 month low of C$60.01 and a 12 month high of C$100.68. The business’s 50-day simple moving average is C$82.00.

Kinaxis (TSE:KXS) last issued its earnings results on Friday, May 10th. The company reported C$0.35 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of C$0.16 by C$0.19. The business had revenue of C$60.83 million for the quarter, compared to analyst estimates of C$59.47 million. As a group, equities research analysts forecast that Kinaxis will post 1.37 EPS for the current year.

In other news, Senior Officer Richard George Monkman sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of C$75.44, for a total value of C$377,183.00. Following the completion of the transaction, the insider now owns 102,027 shares of the company’s stock, valued at C$7,696,569.99. Also, Director John Ernest Sicard sold 1,900 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of C$80.00, for a total value of C$152,000.00. Following the completion of the transaction, the director now directly owns 48,989 shares of the company’s stock, valued at approximately C$3,919,120. In the last three months, insiders have sold 11,100 shares of company stock valued at $880,723.

About Kinaxis

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. The company offers RapidResponse, which provide supply chain planning and analytics capabilities for managing various supply chain management processes, including demand planning, supply planning, inventory management, order fulfillment, capacity planning, and master scheduling, as well as sales and operations planning process.

Further Reading: How Do Tariffs Affect Trade Balances?

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pinduoduo  Shares Up 16% After Better-Than-Expected Earnings
Pinduoduo Shares Up 16% After Better-Than-Expected Earnings
Stein Mart  Shares Up 19%
Stein Mart Shares Up 19%
Sienna Biopharmaceuticals  Stock Price Up 19.7%
Sienna Biopharmaceuticals Stock Price Up 19.7%
Harpoon Therapeutics  Stock Price Up 19.9%
Harpoon Therapeutics Stock Price Up 19.9%
XPEL  Stock Price Up 23.2%
XPEL Stock Price Up 23.2%
Arcadia Biosciences  Stock Price Up 25.4%
Arcadia Biosciences Stock Price Up 25.4%


© 2006-2019 Ticker Report